Linfoma primário do sistema nervoso central: estratégias relevantes na conduta inicial by Malheiros, Suzana Maria Fleury
205
EDITORIAL
Primary central nervous system lymphoma: 
relevant strategies for the initial management
Linfoma primário do sistema nervoso central: estratégias relevantes na conduta inicial
Suzana M. F. Malheiros
Primary central nervous system (CNS) lymphoma (PCNSL) is a relatively uncommon and aggressive extranodal non-Hodgkin lymphoma arising exclusively in the CNS that quite often presents a diagnostic challenge for several medical specialties, particularly for neurologists and neurosurgeons.
Diffuse large B-cell lymphoma comprises approximately 90% of PCNSL. However, its 
prognosis is usually poorer than other extranodal diffuse large B-cell lymphomas, and 
therapeutic results are still disappointing. The limited available data about the molecular 
biology and pathophysiology of PCNSL precludes further advances in the development of 
new therapeutic approaches1. 
PCNSL usually presents with a rapid onset in a variety of clinical syndromes including 
progressive encephalopathy or focal neurological deficits. Brain imaging often demonstrates 
enhancing lesions mimicking primary brain tumor, CNS infection, demyelinating disease and 
autoimmune or paraneoplastic syndromes. Both clinical presentation and neuroimaging fea-
tures may be drastically improved with corticosteroid use, making the high index of suspicious 
a crucial step in the management of this condition. 
The diagnostic evaluation of suspected PCNSL aims to confirm the diagnosis and define 
the extent of the disease besides excluding systemic involvement. Although there is little con-
sensus, the systematic assessment of the available imaging, laboratory tests and biopsy targets 
can guide the evaluation and avoid unnecessary testing or delays in diagnosis. 
Recently, Scott et al.2 conducted a review of the literature and proposed a systematic approach to 
the diagnosis of suspected PCNSL. The complete workout should include laboratory tests (complete 
blood count (CBC), HIV antibody, serum protein electrophoresis); neuroimaging (Magnetic 
Resonance Imaging (MRI); cerebrospinal fluid (CSF), if neuroimaging shows no risk of her-
niation; ophthalmologic examination; computed tomography (CT) or FDG-PET of the chest, 
abdomen and pelvis; and testicular ultrasonography (in males, especially >60 years of age). 
Ideally, once the diagnosis is suspected, the patient should not receive corticosteroids and 
should undergo a stereotactic confirmatory biopsy. 
Methotrexate-based chemotherapy in different regimens is the basis of PCNSL treatment, 
usually followed by consolidation radiation therapy. Although chemoradiation has been the 
standard treatment for PCNSL patients for many years, the high frequency of neurotoxicity as-
sociated with this regimen remains challenging1. New therapeutic strategies are highly desirable 
to improve disease control and prevent neurotoxicity. 
In this issue of Arquivos de Neuro-Psiquiatria, Perini and colleagues3 present a practical 
and useful review focused on the main strategies in the initial management of PCNSL. Some key 
points are emphasized:
1. The relatively low incidence and the dismal prognosis of PCNSL.
2. The importance of differentiating primary CNS lymphoma from secondary CNS lymphoma.
3. The differential diagnosis and the so called “vanishing tumor” syndrome.
4. The diagnosis confirmation preferably based on stereotactic biopsy rather than 
surgical resection.
5. The differences between the management of PCNSL and systemic lymphoma.
6. The pros and cons of radiation therapy.
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PCNSL is a complex disease that requires a multidis-
ciplinary approach. Neurologists and neurosurgeons are 
often the primary care physicians of these patients and 
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